Literature DB >> 2998540

Five cases of cyclical Cushing's syndrome.

A B Atkinson, A L Kennedy, D J Carson, D R Hadden, J A Weaver, B Sheridan.   

Abstract

Reported cases of cyclical Cushing's syndrome are rare. Of 14 successive patients with Cushing's syndrome nine collected sequential urine samples for the estimation of cortisol:creatinine ratio. Five had cyclical Cushing's syndrome while two had considerable variation in urinary cortisol excretion without a cyclical pattern being established. Two of the five patients with a cyclical syndrome had paradoxical responses to dexamethasone. In only one patient with a cyclical pattern did the cortisol:creatinine ratio fall after treatment with bromocriptine or cyproheptadine, or both. The high incidence of the cyclical form of Cushing's syndrome has important clinical implications. A high index of suspicion of the syndrome is required in patients with symptoms or signs of Cushing's syndrome but with normal cortisol values, in patients with fluctuating cortisol values, and in patients with anomalous responses to dexamethasone. Because of possible variations in steroidogenesis the results of drug studies in Cushing's syndrome must be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998540      PMCID: PMC1418075          DOI: 10.1136/bmj.291.6507.1453

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  29 in total

1.  Fluctuating steroid excretion in Cushing's syndrome.

Authors:  H H BASSOE; R EMBERLAND; K F STOA
Journal:  Acta Endocrinol (Copenh)       Date:  1958-06

2.  Cyclical Cushing's Syndrome.

Authors:  C P Aber; H D Cheetham
Journal:  Br Med J       Date:  1961-02-04

Review 3.  Factors influencing the assay of creatinine.

Authors:  J G Cook
Journal:  Ann Clin Biochem       Date:  1975-11       Impact factor: 2.057

4.  Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.

Authors:  R D Brown; G R Van Loon; D N Orth; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

5.  A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique.

Authors:  D Riad-Fahmy; G F Read; S J Gaskell; J Dyas; R Hindawi
Journal:  Clin Chem       Date:  1979-05       Impact factor: 8.327

6.  Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.

Authors:  D E Schteingart; A K McKenzie
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

7.  Bromocriptine and endocrine disorders.

Authors:  R F Spark; G Dickstein
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

8.  Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.

Authors:  R M Jordan; A Ramos-Gabatin; J W Kendall; D Gaudette; R C Walls
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

Review 9.  Cushing syndrome: current concepts of diagnosis and therapy.

Authors:  D M Cook; J W Kendall; R Jordan
Journal:  West J Med       Date:  1980-02

10.  Cyproheptadine in the control of Cushing's disease.

Authors:  T H Hsu; D S Gann; K W Tsan; R P Russell
Journal:  Johns Hopkins Med J       Date:  1981-08
View more
  17 in total

1.  Cyclical Cushing's disease and its successful control under sodium valproate.

Authors:  A Beckers; A Stevenaert; G Pirens; P Flandroy; J Sulon; G Hennen
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Cushing's syndrome with intermittent ectopic ACTH production.

Authors:  A van Coevorden; E Laurent; F Rickaert; O van Reeth; E Van Cauter; J Mockel
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

3.  Periodic hypokalemia associated with cyclic Cushing's syndrome.

Authors:  Hiroaki Kikuchi; Takanobu Yoshimoto; Hiroyuki Tanaka; Kazutaka Tsujimoto; Chisato Yamamura; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Makoto Aoyagi; Yoshihiro Ogawa; Teiichi Tamura
Journal:  CEN Case Rep       Date:  2013-08-09

Review 4.  Cyclic Cushing's syndrome: an overview.

Authors:  Franco Mantero; Carla M Scaroni; Nora M E Albiger
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Recurrent thromboembolism as a hallmark of Cushing's syndrome.

Authors:  A La Brocca; M Terzolo; A Pia; P Paccotti; P De Giuli; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 6.  The evaluation and management of subclinical pituitary disease.

Authors:  S G Soule; H S Jacobs
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

7.  Repeated remissions of Cushing's disease due to recurrent infarctions of an ACTH-producing pituitary macroadenoma.

Authors:  Abdullah Alarifi; Ali S Alzahrani; Suzan Abdel Salam; Mohammed Ahmed; Imaduddin Kanaan
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

8.  Cyproheptadine treatment in Cushing's disease.

Authors:  R Tanakol; F Alagöl; H Azizlerli; O Sandalci; T Terzioğlu; F Berker
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

9.  High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.

Authors:  T C Friedman; D E Ghods; H K Shahinian; L Zachery; N Shayesteh; S Seasholtz; E Zuckerbraun; M L Lee; I E McCutcheon
Journal:  Horm Metab Res       Date:  2010-08-27       Impact factor: 2.936

10.  Cyclic Cushing syndrome due to an ectopic pituitary adenoma.

Authors:  Rahfa K Zerikly; Esin Eray; Charles Faiman; Richard Prayson; Robert R Lorenz; Robert J Weil; Amir H Hamrahian
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.